Cargando…
Tumor Suppressor Gene-Based Nanotherapy: From Test Tube to the Clinic
Cancer is a major health problem in the world. Advances made in cancer therapy have improved the survival of patients in certain types of cancer. However, the overall five-year survival has not significantly improved in the majority of cancer types. Major challenges encountered in having effective c...
Autores principales: | Shanker, Manish, Jin, Jiankang, Branch, Cynthia D., Miyamoto, Shinya, Grimm, Elizabeth A., Roth, Jack A., Ramesh, Rajagopal |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065904/ https://www.ncbi.nlm.nih.gov/pubmed/21490751 http://dx.doi.org/10.1155/2011/465845 |
Ejemplares similares
-
Tumor Microenvironment Targeted Nanotherapy
por: Fernandes, Clara, et al.
Publicado: (2018) -
Phosphorylation of interleukin (IL)-24 is required for mediating its anti-cancer activity
por: Panneerselvam, Janani, et al.
Publicado: (2015) -
Imaging-assisted anticancer nanotherapy
por: Dasgupta, Anshuman, et al.
Publicado: (2020) -
Oxygen‐Independent Sulfate Radical for Stimuli‐Responsive Tumor Nanotherapy
por: Ding, Dandan, et al.
Publicado: (2022) -
Nanomedicine‐Enabled/Augmented Cell Pyroptosis for Efficient Tumor Nanotherapy
por: Zhang, Zheng, et al.
Publicado: (2022)